Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Enterprise Value: 2013-2024

Historic Enterprise Value for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $1.1 billion.

  • Surgery Partners' Enterprise Value rose 46342.03% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 46342.03%. This contributed to the annual value of $1.1 billion for FY2024, which is 3356.82% up from last year.
  • Surgery Partners' Enterprise Value amounted to $1.1 billion in FY2024, which was up 3356.82% from $851.4 million recorded in FY2023.
  • In the past 5 years, Surgery Partners' Enterprise Value registered a high of $1.1 billion during FY2024, and its lowest value of -$59.7 million during FY2021.
  • Its 5-year average for Enterprise Value is $395.4 million, with a median of $59.1 million in 2022.
  • In the last 5 years, Surgery Partners' Enterprise Value tumbled by 43783.78% in 2021 and then soared by 134060.91% in 2023.
  • Annual analysis of 5 years shows Surgery Partners' Enterprise Value stood at -$11.1 million in 2020, then plummeted by 437.84% to -$59.7 million in 2021, then surged by 198.99% to $59.1 million in 2022, then surged by 1340.61% to $851.4 million in 2023, then surged by 33.57% to $1.1 billion in 2024.
  • Its Enterprise Value stands at $1.1 billion for FY2024, versus $851.4 million for FY2023 and $59.1 million for FY2022.